Long-Term Outcomes of Once Daily Accelerated Partial Breast Irradiation with Tomotherapy: Results of a Phase II Trial.

Ugo de Paula,Rolando Maria D'Angelillo, Angela Damiana Andrulli, Giuseppina Apicella,Cristina Caruso, Christian Ghini,Sara Gomellini, Elisabetta Ponti, Marco Pompei, Aurelia Caccavari Mp, Alessandra Petrocchi Mp,Leopoldo Costarelli, Marco Giordano,Massimo La Pinta, Emanuele Zarba Meli,Maria Mauri,Mauro Minelli,Rosalinda Rossi,Paola Scavina,Laura Broglia, Tatiana Ponzani,Andrea Loreti,Lucio Fortunato

International journal of radiation oncology, biology, physics（2020）

引用 3|浏览30

暂无评分

摘要

This phase II trial on APBI-TomoTherapy shows excellent long-term results. Once-daily fractionation schedule was well tolerated with a low rate of adverse events and worse cosmetic outcome. In this series, even among those deemed cautionary or unsuitable for APBI by ASTRO criteria, we demonstrated a low rate of IBTR.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要